Tan Lab

Publications

Densi, A; Tan, M; Sütterlin, C. Inducible Protein Knockdown via Engineered Small RNAs in Chlamydia. 2027:231-241.

Rizvi, SMA; Hakiem, OR; Tan, M. Genome-Wide Quantification of Protein-DNA Interactions in Chlamydia Using ChIP-Seq (Chromatin Immunoprecipitation/Deep Sequencing). 2027:139-150.

Boutin, C-A; Callegari, M; Florescu, D; Nguyen, M-H; Kaul, D; Avery, R; Chong, P; Fisher, C; Limaye, AP; Clough, L; Daud, A; Lorenzo-Redondo, R; Tan, M; Ison, MG. A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients. American Journal of Transplantation. 2026; 26(9):2169-2181.

Xia, M; Ichou, M; Landivar, M; Zhou, P; Vadlamudi, SN; Leruth, A; Nyblade, C; Cox, P; Yuan, L; Goepp, J; Tan, M. Avian Immunoglobulin Y Antibodies Targeting the Protruding or Shell Domain of Norovirus Capsid Protein Neutralize Norovirus Replication in the Human Intestinal Enteroid System. Vaccines. 2025; 13(12).

Xia, M; Huang, P; Vago, FS; Jiang, W; Tan, M. Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges. Vaccine. 2025; 46:126585.

Xia, M; Huang, P; Vago, FS; Jiang, W; Jiang, X; Tan, M. A Nanoparticle Comprising the Receptor-Binding Domains of Norovirus and Plasmodium as a Combination Vaccine Candidate. Vaccines. 2025; 13(1).

Ma, J; Chen, Q; Yuan, F; Cao, M; Gao, J; Yang, C; Tan, M; Xian, R; Gao, L; Kuai, W. Prevalence and genotype distribution of norovirus in Ningxia Hui Autonomous Region, China, from 2011 to 2022. Virology Journal. 2024; 21(1):232.

Huang, P; Xia, M; Vago, FS; Jiang, W; Tan, M. A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge. Vaccines. 2024; 12(8).

Xia, M; Huang, P; Vago, F; Kawagishi, T; Ding, S; Greenberg, HB; Jiang, W; Tan, M. A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses. ACS Nano. 2024; 18(8):6673-6689.

Tan, M. The Impact of Norovirus on Children and Adolescents: Implications for Ongoing Vaccine Development. Current Pediatrics Reports. 2024; 13(1):21.

Xia, M; Huang, P; Vago, F; Jiang, W; Tan, M. Pseudovirus Nanoparticles Displaying Plasmodium Circumsporozoite Proteins Elicited High Titers of Sporozoite-Binding Antibody. Vaccines. 2023; 11(11).

Xia, M; López, K; Vago, FS; Huang, P; Auguste, DI; Jiang, W; Auguste, AJ; Tan, M. A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge. Biotechnology Journal. 2023; 18(10):e2300130.

Hensley, C; Nyblade, C; Zhou, P; Parreño, V; Ramesh, A; Frazier, A; Frazier, M; Garrison, S; Fantasia-Davis, A; Cai, R; Huang, P-W; Xia, M; Tan, M; Yuan, L. Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix® and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection. Vaccines. 2023; 11(5).

Kawagishi, T; Sánchez-Tacuba, L; Feng, N; Costantini, VP; Tan, M; Jiang, X; Green, KY; Vinjé, J; Ding, S; Greenberg, HB. Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses. Proceedings of the National Academy of Sciences of the United States of America. 2023; 120(9):e2214421120.

Xia, M; Vago, F; Han, L; Huang, P; Nguyen, L; Boons, G-J; Klassen, JS; Jiang, W; Tan, M. The αTSR Domain of Plasmodium Circumsporozoite Protein Bound Heparan Sulfates and Elicited High Titers of Sporozoite Binding Antibody After Displayed by Nanoparticles. International Journal of Nanomedicine. 2023; 18:3087-3107.